A notable advancement in diabetes management is emerging with the approval of tirzepatide 45mg. This new formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 receptor, and provides a https://neilueir768995.wikicarrier.com/1296019/significant_introduction_tirzepatide_dose_for_glucose_control